We serve Chemical Name:1-morpholin-4-ylbutan-2-amine CAS:847798-58-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-morpholin-4-ylbutan-2-amine
CAS.NO:847798-58-7
Synonyms:1-morpholin-4-ylbut-2-ylamine;1-Morpholin-4-ylmethyl-propylamine
Molecular Formula:C8H18N2O
Molecular Weight:158.24100
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.49000
Exact Mass:158.14200
LogP:0.69410
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-morpholin-4-ylbut-2-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Morpholin-4-ylmethyl-propylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-morpholin-4-ylbut-2-ylamine Use and application,1-Morpholin-4-ylmethyl-propylamine technical grade,usp/ep/jp grade.
Related News: Importance of evaluating biocatalytic processes during development 2,6-Dimethyl-4-(2-methylsulfanyl-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-cyclopropylmethyl ester 5-methyl ester manufacturers Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. 2-Methyl-1.4-naphtochinon-4-(N-3-(4-methoxy-phenyl)-semicarbazon) suppliers Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. 2,3-Dicyano-but-2-enedinitrile; compound with 2-methyl-phenol vendor & factory Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. ,Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry.
